~nytimes-most-popular | Bookmarks (8)

Many people in the United States are taking five or more prescription drugs. That can lead to serious complications.

A number of new tech companies want to solve the opioid crisis with algorithms. It’s a flawed and potentially harmful proposition.

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.

The hacking shut down the nation’s biggest health care payment system, causing financial chaos that affected a broad spectrum ranging from large hospitals to single-doctor practices.

Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.

Singulair, now a generic, is still used by millions of people in the United States even after thousands of patients and dozens of studies have described harm.

The agency authorized Florida to purchase medicines directly from wholesalers in Canada, where prices are far cheaper. Pharmaceutical companies oppose the plan.